IP Library › Granted Patent US 11,786,630
Granted Patent B2
US 11,786,630 · App. 17/468,384 · Granted Oct 17, 2023

Polymer particles

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Gloria Hincapie (Aliso Viejo, CA); Clayton Harris (Aliso Viejo, CA)
Assignee: Terumo Corporation
A61L24/001A61K9/0029A61K9/1635A61L24/06A61L31/048C08F220/38C08F220/382C08F220/56A61K9/19A61L2430/36C08F222/102C08F222/1006C08F222/385C08F222/408C08L33/02C08L33/14C08L33/26C08L2203/02C08L2312/00Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,630
App. No.
17/468,384
Granted
Oct 17, 2023
Kind
B2
Abstract

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

Claims (23)

1. A polymer particle including:

at least one monomer including at least one functional group; and

at least one crosslinker including at least two functional groups and at least one linkage susceptible to breakage to impart biodegradation to the polymer particle;

wherein the polymer particle has a spherical diameter between about 40 μm and about 1,200 μm, and a circularity greater than about 0.9.

2. The polymer particle of claim 1 , wherein the biodegradation provides less than about 10% of the polymer particle intact after about 5 days.

3. The polymer particle of claim 1 , wherein the spherical diameter is between about 75 μm and about 1,200 μm.

4. The polymer particle of claim 1 , wherein the biodegradation is through hydrolysis or enzymatic action.

5. The polymer particle of claim 1 , wherein the at least one crosslinker is bis-glycidyl amino alcohol,

wherein a, b, c, d, e, and f are each independently 1-20.

6. The polymer particle of claim 1 , wherein the at least one linkage is an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, a peptide cleavable by matrix cathepsins, or a combination thereof.

7. The polymer particle of claim 1 , wherein the at least one crosslinker is bis-glycidyl amino alcohol or bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

8. The polymer particle of claim 1 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins.

9. The polymer particle of claim 1 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide.

10. The polymer particle of claim 1 , wherein the at least one monomer includes an ionizable functional group.

11. The polymer particle of claim 10 , wherein the ionizable functional group is basic or acidic.

12. The polymer particle of claim 1 , wherein the at least one monomer is dimethylacrylamide and the at least one crosslinker is bis-glycidyl amino alcohol.

13. The polymer particle of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

14. An embolic solution including a plurality of the polymer particle of claim 1 .

15. The embolic solution of claim 14 , wherein the solution is sterilized.

16. The embolic solution of claim 14 , including a radiopaque contrast agent.

17. The embolic solution of claim 14 , including a dye.

18. A method of treatment, the method comprising administering the embolic solution of claim 14 to a location in need thereof.

19. The method of claim 18 , wherein the location is in a vessel.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2021
From: CRUISE, GREGORY M.; HINCAPIE, GLORIA; HARRIS, CLAYTON
To: MICROVENTION, INC.
Reel/Frame 057403/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2021
From: MICROVENTION, INC.
To: TERUMO CORPORATION
Reel/Frame 057403/0578 →
Continuity (8)
Continuation 16516931 · Jul 19, 2019
Continuation 16175609 · Oct 30, 2018
Continuation 15910976 · Mar 2, 2018
Continuation 15630048 · Jun 22, 2017
Continuation 15369213 · Dec 5, 2016
Continuation 14491776 · Sep 19, 2014
Provisional Application 61880036 · Sep 19, 2013
Related Publication 20210401749A1 · Dec 30, 2021
Cited By (2)
US 12,364,786 US 12,447,228